Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-57

I'm also in it until BOT gets taken over, and/or at least till it reaches $1. I see $1 as a reasonable target based on SOFDRA sales alone. So if we get to that mark and we still haven't been taken over, I will reconsider at the time. I do think that $5 potential could be there one day with their pipeline, but obviously that still has some hoops to get through and is years away I think (unless of course some buyer sees the value earlier). That's not to say the trader's can't make a quid too - just not my scene is all ( I hold BOT across 4 different entities for tax purposes - so just too hard for me trying to sell, buy, sell, buy, and then also lose the CGT exemption benefits).